DRRXDurectDRRX info
$1.35info-4.93%24h
Global rank26428
Market cap$40.27M
Change 7d-11.18%
YTD Performance128.81%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Durect (DRRX) Stock Overview

    DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.

    DRRX Stock Information

    Symbol
    DRRX
    Address
    10260 Bubb RoadCupertino, CA 95014-4166United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.durect.com
    Country
    🇺🇸 United States
    Phone Number
    408 777 1417

    Durect (DRRX) Price Chart

    -
    Value:-

    Durect Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.35
    N/A
    Market Cap
    $40.27M
    N/A
    Shares Outstanding
    29.83M
    N/A
    Employees
    72.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org